NO961297L - Ranitidine and calcium carbonate pharmaceutical product - Google Patents

Ranitidine and calcium carbonate pharmaceutical product

Info

Publication number
NO961297L
NO961297L NO961297A NO961297A NO961297L NO 961297 L NO961297 L NO 961297L NO 961297 A NO961297 A NO 961297A NO 961297 A NO961297 A NO 961297A NO 961297 L NO961297 L NO 961297L
Authority
NO
Norway
Prior art keywords
calcium carbonate
ranitidine
pharmaceutical product
carbonate pharmaceutical
pharmaceutical preparation
Prior art date
Application number
NO961297A
Other languages
Norwegian (no)
Other versions
NO961297D0 (en
Inventor
Mark Alan Sirgo
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of NO961297D0 publication Critical patent/NO961297D0/en
Publication of NO961297L publication Critical patent/NO961297L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytisk preparat for mage/tarmtilstander omfattende ranitidin og kalsiumkarbonat.Pharmaceutical preparation for gastrointestinal disorders including ranitidine and calcium carbonate.

NO961297A 1993-09-30 1996-03-29 Ranitidine and calcium carbonate pharmaceutical product NO961297L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12951793A 1993-09-30 1993-09-30
PCT/US1994/011132 WO1995008997A1 (en) 1993-09-30 1994-09-29 Ranitidine and calcium carbonate pharmaceutical combination product

Publications (2)

Publication Number Publication Date
NO961297D0 NO961297D0 (en) 1996-03-29
NO961297L true NO961297L (en) 1996-03-29

Family

ID=22440376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961297A NO961297L (en) 1993-09-30 1996-03-29 Ranitidine and calcium carbonate pharmaceutical product

Country Status (17)

Country Link
EP (1) EP0721338A1 (en)
JP (1) JPH09503212A (en)
CN (1) CN1140996A (en)
AU (1) AU677108B2 (en)
BG (1) BG100456A (en)
CA (1) CA2168846A1 (en)
CZ (1) CZ76996A3 (en)
HU (1) HUT75061A (en)
IL (1) IL111094A0 (en)
NO (1) NO961297L (en)
NZ (1) NZ274713A (en)
OA (1) OA10717A (en)
PL (1) PL316855A1 (en)
SG (1) SG44715A1 (en)
SK (1) SK40596A3 (en)
WO (1) WO1995008997A1 (en)
ZA (1) ZA947553B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5560701B2 (en) * 2008-12-26 2014-07-30 ライオン株式会社 Ranitidine-containing pharmaceutical solid preparation and method for producing ranitidine-carrying particles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222772B (en) * 1988-09-20 1992-05-13 Glaxo Group Ltd Pharmaceutical compositions
WO1992000102A1 (en) * 1990-06-22 1992-01-09 Beecham Group Plc Novel treatment
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
SK40596A3 (en) 1997-02-05
NO961297D0 (en) 1996-03-29
AU677108B2 (en) 1997-04-10
CA2168846A1 (en) 1995-04-06
SG44715A1 (en) 1997-12-19
CZ76996A3 (en) 1996-10-16
IL111094A0 (en) 1994-11-28
NZ274713A (en) 1997-10-24
CN1140996A (en) 1997-01-22
AU7925394A (en) 1995-04-18
EP0721338A1 (en) 1996-07-17
JPH09503212A (en) 1997-03-31
ZA947553B (en) 1995-05-26
PL316855A1 (en) 1997-02-17
BG100456A (en) 1996-11-29
HUT75061A (en) 1997-03-28
HU9600810D0 (en) 1996-05-28
OA10717A (en) 2002-12-09
WO1995008997A1 (en) 1995-04-06

Similar Documents

Publication Publication Date Title
IS1846B (en) Substituted N- (indole-2-carbonyl) -b-alaninamide, their use and drug formulations
NO993519L (en) Fenofibrate pharmaceutical composition having high bioavailability and process for the preparation thereof.
AU6948994A (en) Iron-binding polymers for oral administration
NO976048D0 (en) Pharmaceutical and diet formulations for prophylaxis and treatment of gastrointestinal disorders
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
IS2457B (en) Compositions of drugs (e.g. chlorpromazine and pentamidine) for the treatment of neoplastic disorders
DE69300913D1 (en) Polymorph terazosin and pharmaceutical composition.
NO306398B1 (en) Substituted N- (indole-2-carbonyl) glycinamides, their use, intermediate and pharmaceutical composition
NO953657L (en) New pharmaceutical product
PL356904A1 (en) Pharmaceutical compositions
DE69426294D1 (en) REHYDRIABLE PRODUCT
DE69419295D1 (en) Double cast product
NO965102L (en) Bicyclic aromatic compounds, uses thereof, and pharmaceutical and cosmetic preparations
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
NO913817L (en) PROCEDURE AND PRODUCT FOR TEXTURING.
JO2017B1 (en) Pharmaceutical-composition for gastric residence
BR9605046B1 (en) n- (pyrimidinyl) -benzenesulfonamide compounds and pharmaceutical preparation containing them.
BR0203501A (en) Biomodulated Multiparticle Formulations
NO961297L (en) Ranitidine and calcium carbonate pharmaceutical product
DE69723873D1 (en) CRYSTALINE PHARMACEUTICAL PRODUCT
NO980471D0 (en) Benzenesulfonamide derivatives, their preparation and therapeutic uses thereof
DZ2159A1 (en) Pharmaceutical products.
ATE269061T1 (en) CALCIUM-CONTAINING effervescent TABLET WITH AN ANTHISTAMINIC AS THE ACTIVE INGREDIENT
ITRM940140A0 (en) PROCEDURE AND DEVICE FOR THE PRODUCTION OF POTAX.
NL1000767A1 (en) Granulation equipment, granulation procedure and granulated product.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application